Vita 34 AG buy melinda
Start price
29.09.18
/
50%
€13.25
Target price
21.01.19
€14.50
Performance (%)
-9.81%
End price
21.01.19
€11.95
Summary
This prediction ended on 21.01.19 with a price of €11.95. With a performance of -9.81%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vita 34 AG | -1.240% | -1.240% | -33.426% | -72.370% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Vita 34 AG diskutieren
SecteurInstallations et services en soins de santé Agenda 22/11 Publication de résultats
Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells.
It operates through Stem Cell Banking segment.
The Stem Cell Banking segment collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes.
The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.
Nombre d'employés : 133 personnes.
(Vom Mitglied beendet)